DurgicalDurgical
EN
Open the app

TNF inhibitors !

Biologic medicines that block TNF-α, a key cytokine of inflammation. Used in rheumatoid arthritis, spondylitis, psoriasis and bowel disease.

Updated 2026-11-01

What they are

Five biologics neutralise tumour necrosis factor alpha (TNF-α): the monoclonal antibodies infliximab, adalimumab and golimumab, the pegylated Fab fragment certolizumab pegol, and the receptor fusion protein etanercept. They control inflammation and slow joint damage when conventional DMARDs such as methotrexate are not enough.

Mechanism of action

TNF-α is made by macrophages and T cells; it activates the endothelium, recruits neutrophils, drives the release of IL-1 and IL-6 and stimulates osteoclasts and synovial cells. Binding soluble and membrane TNF stops this cascade. The same cytokine keeps granulomas closed, which is why latent tuberculosis can reactivate.

Target: Tumour necrosis factor alpha (TNF-α)

Drugs in this class

Test yourself

Think of the answer, then tap the question to see it.

Which test must be done before starting any TNF inhibitor, and why?

A test for latent tuberculosis (skin test or interferon-gamma release assay): TNF keeps granulomas intact, so blocking it can reactivate TB.

Which TNF inhibitor is a receptor fusion protein rather than an antibody?

Etanercept: the TNF receptor 2 ectodomain joined to the Fc part of human IgG1.

In which two conditions are TNF inhibitors avoided or used with great caution?

Heart failure (it can worsen) and demyelinating disease such as multiple sclerosis.

Add to my cards (3)

← All of pharmacology

Educational content on how drugs work; not a prescribing guide and no substitute for a health professional's advice. No doses are given.

Sources: DailyMed - ADALIMUMAB- adalimumab-adaz injection, solution (DailyMed (U.S. National Library of Medicine), 2025); DailyMed - INFLIXIMAB injection, powder, lyophilized, for solution (DailyMed (U.S. National Library of Medicine), 2025); Altered Immunocompetence | Vaccines & Immunizations | CDC (Centers for Disease Control and Prevention (CDC), 2024); Goodman & Gilman's The Pharmacological Basis of Therapeutics, 14th ed., ch. 39 (McGraw Hill, 2023).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.